Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
876.6 INR | -0.27% |
|
+0.86% | +15.43% |
28/06 | Alembic Pharmaceuticals Gets US FDA's Nod for Generic Inflammatory Skin Condition Drug | MT |
18/06 | Alembic Pharmaceuticals Gets US FDA Nod for Dabigatran Etexilate Capsules | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.43% | 206.7Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+2.04% | 22TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr |
- Stock Market
- Equities
- APLLTD Stock
- News Alembic Pharmaceuticals Limited
- Transcript : Alembic Pharmaceuticals Limited, Q4 2021 Earnings Call, May 04, 2021